Xcision Receives FDA 510(k) Clearance for the GammaPod Stereotactic Radiotherapy System for Breast Cancer
COLUMBIA, Md., Jan. 9, 2018 -- (Healthcare Sales & Marketing Network) -- Xcision Medical Systems, LLC has announced that the GammaPod Stereotactic Radiotherapy System, the world's first noninvasive external beam system optimized for partial breast treatme... Devices, Oncology, FDA Xcision Medical Systems, GammaPod, Stereotactic, Radiotherapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | External Beam Therapy | Marketing | Pharmaceuticals